Seeking a Cure for One of the Rarest Diseases: Progeria-Reference-Cited by-同舟云学术

Seeking a Cure for One of the Rarest Diseases: Progeria

Published:2016-07-12 Issue:2 Volume:134 Page:126-129
ISSN:0009-7322
Container-title:Circulation
language:en
Short-container-title:Circulation

Author:

Collins Francis S.¹

Affiliation:

1. From Medical Genomics and Metabolic Genetics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

Link

https://www.ahajournals.org/doi/pdf/10.1161/CIRCULATIONAHA.116.022965

Reference19 articles.

1. Online Mendelian Inheritance in Man. OMIM Gene Map Statistics. http://www.omim.org/statistics/geneMap. Accessed May 19 2016.

2. National Institutes of Health. About NCATS National Center for Advancing Translational Sciences. https://ncats.nih.gov/about. Accessed May 19 2016.

3. Clinical Trial of the Protein Farnesylation Inhibitors Lonafarnib, Pravastatin, and Zoledronic Acid in Children With Hutchinson-Gilford Progeria Syndrome

4. Progeria: Translational insights from cell biology

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Drug Repositioning Based on Deep Sparse Autoencoder and Drug–Disease Similarity;Interdisciplinary Sciences: Computational Life Sciences;2023-12-16

2. STAT1 Drives the Interferon-Like Response and Aging Hallmarks in Progeria;Aging Biology;2023-06-30

3. Lonafarnib and everolimus reduce pathology in iPSC-derived tissue engineered blood vessel model of Hutchinson-Gilford Progeria Syndrome;Scientific Reports;2023-03-28

4. Modelling premature cardiac aging with induced pluripotent stem cells from a hutchinson-gilford Progeria Syndrome patient;Frontiers in Physiology;2022-11-23

5. GCMM: graph convolution network based on multimodal attention mechanism for drug repurposing;BMC Bioinformatics;2022-09-13